Barrons.com1d agobearish
Merck Delivers a Clean Earnings Beat on Oncology Strength. Is It Enough to Impress Wall Street?The drugmaker posts a narrower-than-expected quarterly loss fueled by growth in its oncology segment.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
530last 24h
2512last 7d
483● bullish (7d)
257● bearish (7d)
197publishers
Quartz5d agobearish
Moderna Q2 earnings beat estimates as norovirus vaccine stumblesThe company topped Wall Street loss estimates, but its norovirus vaccine missed a key trial goal, sending shares lower